TAVYLBY

Swiss trademark · 748121 · Word mark · In force

Register entry

Registration number
748121
Application number
07820/2020
Status
In force
Type
Word mark
Filed
Jun 8, 2020
Registered
Jun 9, 2020
Published
Jun 9, 2020
Protected until
Jun 8, 2030
Priority
04.06.2020 US
Language of procedure
German
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate zur Verwendung bei der Behandlung menschlicher Krankheiten, nämlich Entzündungs- und Autoimmunerkrankungen, -störungen und -syndromen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 30, 2025

    Holder’s address changed

    Owner
    ChemoCentryx, Inc., 850 Maude Ave., Mountain View, California 94043, USA → ChemoCentryx, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA

    Published in Swissreg on 30.05.2025

  2. May 28, 2025

    Agent removed

    Representative
    WEINMANN ZIMMERLI, Carmenstrasse 28, 8032 Zürich (removed)

    Published in Swissreg on 28.05.2025

  3. May 28, 2025

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 28.05.2025

  4. Dec 17, 2024

    Agent’s address changed

    Representative
    WEINMANN ZIMMERLI, Apollostrasse 2, Postfach, 8032 Zürich → WEINMANN ZIMMERLI, Carmenstrasse 28, 8032 Zürich

    Published in Swissreg on 17.12.2024

  5. Jun 9, 2020

    Registered

    Published in Swissreg on 09.06.2020

Parties

Holder

ChemoCentryx, Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.